NDRG1 prognosticates the natural course of disease in WHO grade II glioma

Jonas Blaes(Heidelberg University), Markus Weiler(German Cancer Research Center), Felix Sahm(University Hospital Heidelberg), Bettina Hentschel(Leipzig University), Matthias Osswald(University Hospital Heidelberg), Marcus Czabanka(Charité - Universitätsmedizin Berlin), Carina M. Thomé(Heidelberg University), Maximilian G. Schliesser(German Cancer Research Center), Stefan Pusch(Heidelberg University), Sebastian Luger(German Cancer Research Center), Frank Winkler(Heidelberg University), Alexander Radbruch(University Hospital Heidelberg), Manfred Jugold(German Cancer Research Center), Matthias Simon(University of Bonn), Jörg Steinbach(University Hospital Frankfurt), Gabriele Schackert(TU Dresden), Marcos Tatagiba(University of Tübingen), Manfred Westphal(University Medical Center Hamburg-Eppendorf), J. C. Tonn(Ludwig-Maximilians-Universität München), Dorothee Gramatzki(University Hospital of Zurich), Torsten Pietsch(University of Bonn), Christian Hartmann(German Cancer Research Center), Hanno Glimm(Heidelberg University), Peter Vajkoczy(MSB Medical School Berlin), Andreas von Deimling(Heidelberg University), Michael Platten(National Center for Tumor Diseases), Michael Weller(University Hospital of Zurich), Wolfgang Wick(Heidelberg University)
Journal of Neuro-Oncology
January 6, 2014
Cited by 22Open Access

Abstract


Related Papers

No related papers found

Powered by citation graph analysis